Company: OSRH
Filing Date: 2025-01-24
Form Type: S-4/A
Source: 0001213900-25-006139
Chunk: 346

Company: OSR Holdings, Inc.
Filing Date: 2025-01-24
Form: S-4/A
Chunk 346
---
000,001, after giving effect to all demands for redemption from holders of our public shares. Any redemptions by our public stockholders will decrease the funds in the Trust Account available to us to consummate the Business Combination and related transactions. Vote Required for Approval The Business Combination Proposal requires the approval of the affirmative vote of the holders of a majority of the shares of BLAC Common Stock outstanding, present and entitled to vote at the BLAC Stockholders’ Meeting. Abstentions will count as a vote against the Business Combination Proposal. Broker non -voteswill have no impact on the outcome of the Business Combination Proposal. Consequently, the transactions contemplated by the Business Combination Agreement, including the Business Combination, cannot be completed unless the Business Combination Proposal is adopted by the affirmative vote of the holders of a majority of the voting power of the outstanding shares of BLAC Common Stock. The consummation of the Business Combination is conditioned on the approval of the Business Combination Proposal as well as the other Condition Precedent Proposals. If the other Condition Precedent Proposals are not approved, this Business Combination will not be consummated, even if the Business Combination Proposal is approved by our stockholders. As of the Record Date, our Sponsor, and those who received BLAC Common Stock from the Sponsor, including Mr. David Yoo, BLAC’s Chief Financial Officer, Mr. Jin Whan Park, a current director of BLAC, and Dr. Steven Reed, Dr. In Chul Chung, Dr. Radclyffe Roberts, and Mr. Hosun Euh, former directors of BLAC, have agreed to vote those shares in favor of the Business Combination Proposal. Those shares of BLAC Common Stock referred to in the prior sentence constitute, collectively, approximately 92.9% of the issued and outstanding shares of BLAC Common Stock as of [•], 2025. Accordingly, BLAC does not need the affirmative vote of any of the shares of BLAC Common Stock held by public stockholders to approve the Business Combination Proposal. Each of Dr. Reed, Dr. Roberts, Dr. Chung, Mr. Euh, Mr. Park and Mr. Yoo obtained their shares of BLAC Common Stock in exchange for their services provided as executive officers or directors of BLAC and were not provided with any other consideration for their agreement to vote their shares in favor of the Business Combination Proposal. Recommendation of the Board of Directors OUR BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT OUR STOCKHOLDERS V